Autolus Therapeutics plc
NASDAQ:AUTL · NASDAQ Global Select
+$0.01 today
Vol 0.83M · Avg 1.60M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-31.67%
Period High
$2.68
Period Low
$1.21
Latest
$1.51
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
RAPT Therapeutics, Inc.
RAPT
$959.26M
LB Pharmaceuticals Inc Common Stock
NASDAQ:LBRX
$848.51M
Solid Biosciences Inc.
NASDAQ:SLDB
$590.95M
Annexon, Inc.
NASDAQ:ANNX
$585.79M
Aura Biosciences, Inc.
NASDAQ:AURA
$399.32M
Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT
$351.06M
Benitec Biopharma Inc.
NASDAQ:BNTC
$316.28M
Neumora Therapeutics, Inc. Common Stock
NASDAQ:NMRA
$271.44M
Quantum-Si incorporated
NASDAQ:QSI
$194.84M
ADC Therapeutics S.A.
NYSE:ADCT
$136.09M
What is the latest AUTL filing?
The latest filing shown is 8-K dated Jun 9, 2026.
How many recent filings does AUTL have?
Intrinsic Alpha currently shows 20 recent filings for AUTL.
Explore More
Continue the stock analysis
Jump to another research area for this company.